Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 17 Show results per page	View Search Criteria \| Help With Results


1.		Phase II/III Chemotherapy with CTX/ADR/5-FU/MTX with and without Cell Synchronization with Tamoxifen and Premarin for Metastatic Breast Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				under 65								NCI-76-C-377A NCI-MB-160A


2.		Phase II/III Chemotherapy with CTX/ADR/MTX/5-FU, with vs without Hormonal Synchronization with TMX/Premarin, for Metastatic Mammary Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				no age specified								NCI-76-C-377B NCI-MB-160B

Last Modified: 5/14/2007 First Published: 7/1/1997


3.		NCI HIGH PRIORITY CLINICAL TRIAL --- Phase III Randomized Study of Estrogen Replacement Therapy Versus Placebo in Women With Stage I or II Endometrial Adenocarcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				Not specified				NCI				GOG-137A E-G0137, SWOG-G0137, NCT00002976, GOG-0137

Last Modified: 3/19/2008 First Published: 11/1/2001


4.		Phase III Randomized Study of Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women With a History of Node-Negative Invasive Carcinoma or Ductal Carcinoma in Situ of the Breast Who are Receiving Adjuvant Tamoxifen

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Completed				18 and over				NCI				E-2193 NCI-P01-0194, NCT00026286, ECOG-E2193

Last Modified: 1/8/2007 First Published: 8/1/2002


5.		Phase III Randomized Study of Calcium and Cholecalciferol With or Without Conjugated Estrogens and With or Without Risedronate for the Prevention of Osteoporosis in Patients With Prostate Cancer Receiving Androgen-Ablation Therapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				18 and over				NCI				NCCTG-N01C8 NCI-P02-0229, N01C8, NCT00043069


6.		Phase III Sequential MTX/5-FU with Continuous TMX vs Sequential MTX/5-FU with Hormonal Synchronization (TMX and Premarin) for Metastatic Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								SEG-BRE-83309


7.		Phase III Therapy with CAMFTP (CTX/ADR/MTX/5-FU/TMX/Premarin) for Inflammatory Stage IV or Stage III Breast Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified				NCI				NCI-76-C-377C NCI-MB-160C, NCI-T83-1293N, T83-1293


8.		Phase III Randomized Study of Therapy with AGT/HC plus CAF (CTX/ADR/5-FU) with or without Premarin Priming in Patients with Metastatic Estrogen or Progesterone Receptor-Positive Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								SEG-BRE-302

Last Modified: 5/18/2006


9.		Phase III Multimodality Approach to Patients with Inflammatory and Locally Advanced Noninflammatory Stage III Carcinoma of the Breast and Metastatic (Stage IV) Breast Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				18 and over				NCI				NCI-84-C-216 BRMP-8607, NCI-86-C-188, NCI-MB-198, NCI-T84-0518N, T84-0518

Last Modified: 4/10/2007


10.		Phase III Randomized Evaluation of MEG Alone vs MEG Following Pretreatment with Premarin in Patients with ER-Positive Metastatic Carcinoma of the Breast

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				over 18				NCI				EST-2185

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute